EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY-NC-ND 4.0

Associations among hypertension, dementia biomarkers, and cognition: The MEMENTO cohort

Jérémie Lespinasse, Geneviève Chêne, Jean-Francois Mangin, Bruno Dubois, Frederic Blanc, Claire Paquet, Olivier Hanon, Vincent Planche, Audrey Gabelle, Mathieu Ceccaldi, Cedric Annweiler, Pierre Krolak-Salmon und 8 weitere

Alzheimer's & Dementia · 2023-06 · 19 (6) · 2332-2342

DOI: 10.1002/alz.12866 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Alzheimer's & Dementia, online erschienen am 04.12.2022. Verfasst von Jérémie Lespinasse und 19 weiteren Autor:innen. Beteiligte Einrichtung: Inserm Research Center « Bordeaux Population Health », Bordeaux School of Public Health, CIC 1401-EC, Bordeaux University, Bordeaux, France. Hauptthemen laut MEDLINE: Alzheimer Disease, Cognitive Dysfunction, Hypertension. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Fondation Plan Alzheimer, Agence Nationale de la Recherche, GE Healthcare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Approximately 40% of dementia cases could be delayed or prevented acting on modifiable risk factors including hypertension. However, the mechanisms underlying the hypertension–dementia association are still poorly understood.

Methods

We conducted a cross‐sectional analysis in 2048 patients from the MEMENTO cohort, a French multicenter clinic‐based study of outpatients with either isolated cognitive complaints or mild cognitive impairment. Exposure to hypertension was defined as a combination of high blood pressure (BP) status and antihypertensive treatment intake. Pathway associations were examined through structural equation modeling integrating extensive collection of neuroimaging biomarkers and clinical data.

Results

Participants treated with high BP had significantly lower cognition compared to the others. This association was mediated by higher neurodegeneration and higher white matter hyperintensities load but not by Alzheimer's disease (AD) biomarkers.

Discussion

These results highlight the importance of controlling hypertension for prevention of cognitive decline and offer new insights on mechanisms underlying the hypertension–dementia association. Highlights Paths of hypertension–cognition association were assessed by structural equation models. The hypertension–cognition association is not mediated by Alzheimer's disease biomarkers. The hypertension–cognition association is mediated by neurodegeneration and leukoaraiosis. Lower cognition was limited to participants treated with uncontrolled blood pressure. Blood pressure control could contribute to promote healthier brain aging.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseCognitive DysfunctionHypertensionHumansCross-Sectional StudiesPositron-Emission TomographyMagnetic Resonance ImagingCognitionBiomarkersAmyloid beta-Peptides

Stichwörter der Autor:innen

amyloid beta 42cognitioncortical thicknessfluorodeoxyglucose positron emission tomographyhippocampal volumehypertensionmediationpositron emission tomography amyloidstructural equation modeltauwhite matter hyperintensities

Substanzen

BiomarkersAmyloid beta-Peptides

Autor:innen und Institutionen

  • Inserm Research Center « Bordeaux Population Health », Bordeaux School of Public Health, CIC 1401-EC, Bordeaux University, Bordeaux, France.
  • Pôle de santé publique, Centre Hospitalier Universitaire (CHU) de Bordeaux, Bordeaux, France.
  • CATI, US52-UAR2031, CEA, ICM, SU, CNRS, INSERM, APHP, Paris, France.
  • Université Paris-Saclay, CEA, CNRS, Neurospin, UMR9027 Baobab, Gif-sur-Yvette, France.
  • Sorbonne Université, CNRS, INSERM, Laboratoire d'Imagerie Biomédicale, Paris, France.
  • Sorbonne-Université, Service des maladies cognitives et comportementales et Institut de la mémoire et de la maladie d'Alzheimer (IM2A), Hôpital de la Salpêtrière, Paris AP-PH, France.

Förderung

  • Fondation Plan Alzheimer
  • Agence Nationale de la Recherche
  • GE Healthcare
  • Fujirebio US

Zitieren

APA

Lespinasse, J., Chêne, G., Mangin, J. F., Dubois, B., Blanc, F., Paquet, C., Hanon, O., Planche, V., Gabelle, A., Ceccaldi, M., Annweiler, C., Krolak-Salmon, P., Godefroy, O., Wallon, D., Sauvée, M., Bergeret, S., Chupin, M., Proust-Lima, C., Dufouil, C., & MEMENTO study group (2023). Associations among hypertension, dementia biomarkers, and cognition: The MEMENTO cohort. Alzheimer's & Dementia, 19(6), 2332-2342. https://doi.org/10.1002/alz.12866

Vancouver

Lespinasse J, Chêne G, Mangin JF, Dubois B, Blanc F, Paquet C, et al. Associations among hypertension, dementia biomarkers, and cognition: The MEMENTO cohort. Alzheimer's & Dementia. 2023;19(6):2332-2342. doi:10.1002/alz.12866

BibTeX
@article{Lespinasse2023,
  author = {Lespinasse, Jérémie and Chêne, Geneviève and Mangin, Jean-Francois and Dubois, Bruno and Blanc, Frederic and Paquet, Claire and Hanon, Olivier and Planche, Vincent and Gabelle, Audrey and Ceccaldi, Mathieu and Annweiler, Cedric and Krolak-Salmon, Pierre and Godefroy, Olivier and Wallon, David and Sauvée, Mathilde and Bergeret, Sébastien and Chupin, Marie and Proust-Lima, Cécile and Dufouil, Carole and MEMENTO study group, MEMENTO study group},
  title = {Associations among hypertension, dementia biomarkers, and cognition: The MEMENTO cohort},
  journal = {Alzheimer's & Dementia},
  year = {2023},
  volume = {19},
  number = {6},
  pages = {2332--2342},
  doi = {10.1002/alz.12866}
}
Kostenlos starten →